Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
10 May 24
8-K
Entera Bio Reports Q1 2024 Financial Results and Provides Business Updates
10 May 24
S-8
Registration of securities for employees
8 Mar 24
10-K
2023 FY
Annual report
8 Mar 24
8-K
Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates
8 Mar 24
8-K
Regulation FD Disclosure
4 Mar 24
424B3
Prospectus supplement
15 Feb 24
EFFECT
Notice of effectiveness
15 Feb 24
S-3/A
Shelf registration (amended)
14 Feb 24
CORRESP
Correspondence with SEC
14 Feb 24
8-K
Regulation FD Disclosure
2 Feb 24
S-3
Shelf registration
2 Feb 24
8-K
Other Events
3 Jan 24
D
$6.61 mm in equity / options / securities to be acquired, sold $6.61 mm, 52 investors
2 Jan 24
8-K
Entry into a Material Definitive Agreement
26 Dec 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Results of Operations and Financial Condition
14 Nov 23
8-K
Submission of Matters to a Vote of Security Holders
13 Sep 23
ARS
2023 FY
Annual report to shareholders
15 Aug 23
DEF 14A
Definitive proxy
15 Aug 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
8-K
Entera Bio Announces Q2 2023 Financial Results and Corporate Updates
11 Aug 23
PRER14A
Preliminary revised proxy
28 Jul 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
30 Jun 23
25-NSE/A
Exchange delisting (amended)
29 Jun 23
8-K
Other Events
27 Jun 23
PRE 14A
Preliminary proxy
23 Jun 23
8-K
Departure of Directors or Certain Officers
7 Jun 23
S-8
Registration of securities for employees
2 Jun 23
10-Q
2023 Q1
Quarterly report
5 May 23
8-K
Entera Bio Announces Q1 2023 Financial Results and Corporate Updates
5 May 23
10-K
2022 FY
Annual report
31 Mar 23
8-K
Results of Operations and Financial Condition
31 Mar 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
23 Nov 22
10-Q
2022 Q3
Quarterly report
10 Nov 22
8-K
Entera Bio Provides Corporate Updates and Financial Results for the Third Quarter of 2022
10 Nov 22
8-K
Other Events
6 Oct 22
8-K
Submission of Matters to a Vote of Security Holders
9 Sep 22
424B5
Prospectus supplement for primary offering
2 Sep 22
8-K
Entry into a Material Definitive Agreement
2 Sep 22
Latest ownership filings
4
Dana Yaacov-Garbeli
23 Apr 24
4
Hillel Galitzer
23 Apr 24
SC 13G/A
Knoll Capital Management, LLC
16 Jan 24
4
Haya Taitel
16 Jan 24
4
Haya Taitel
11 Jan 24
4
Haya Taitel
3 Jan 24
4
ROGER GARCEAU
3 Jan 24
4
Yonatan Malca
3 Jan 24
4
GERALD M OSTROV
3 Jan 24
4
Ron Mayron
3 Jan 24
4
GERALD M LIEBERMAN
3 Jan 24
4
Sean Ellis
3 Jan 24
4
GERALD M LIEBERMAN
27 Dec 23
4
Miranda Jayne Toledano
27 Dec 23
4
Haya Taitel
14 Sep 23
4
Miranda Jayne Toledano
14 Sep 23
4
Haya Taitel
24 Aug 23
3
Haya Taitel
24 Aug 23
4
GERALD M LIEBERMAN
23 Aug 23
4
Sean Ellis
22 Aug 23
4
Arthur C Santora II
25 Apr 23
4
Dana Yaacov-Garbeli
25 Apr 23
4
Hillel Galitzer
25 Apr 23
4
Miranda Jayne Toledano
6 Apr 23
SC 13G/A
RA CAPITAL MANAGEMENT, L.P.
14 Feb 23
4
ROGER GARCEAU
4 Jan 23
4
GERALD M LIEBERMAN
4 Jan 23
4
Ron Mayron
4 Jan 23
4
GERALD M OSTROV
4 Jan 23
4
Yonatan Malca
4 Jan 23
4
Sean Ellis
4 Jan 23
SC 13G/A
CENTILLION FUND INC.
18 Nov 22
SC 13G/A
CENTILLION FUND INC.
18 Nov 22
SC 13G/A
CENTILLION FUND INC.
18 Nov 22
4
Dana Yaacov-Garbeli
15 Nov 22
4
GERALD M LIEBERMAN
15 Nov 22
4
Sean Ellis
14 Nov 22
4
Miranda Jayne Toledano
14 Nov 22
SC 13G/A
CENTILLION FUND INC.
10 Nov 22
4
Arthur C Santora II
9 Sep 22